Over the last six decades in the U.S., gastric, or stomach, cancer rates have plummeted. But around the world, gastric cancer remains a leading cause …
Tag: cancer
A 2022 recap: Most read, most viewed and most popular on social media
As the year comes to a close, we're sharing the most-read stories, most-viewed videos and most popular stories on social media of 2022.
Exploring the ordinary and extraordinary in end-of-life care, death
Stanford physician Samuel LeBaron discusses his book, which covers death and how to prepare for and receive end-of-life care.
Molecules, shmolecules. Why should you care?
We explore the most basic molecular elements of human biology in the lead story for the latests issue of Stanford Medicine magazine.
Coming full circle with extrachromosomal DNA, cancer and Ptolemy
Research into the destructive influence tiny DNA circles have on cancer presents endless ideas for clearly describing groundbreaking science.
Building a cancer community through BLACC
A group of Black women work toward a peer navigation program to help other Black women survive breast cancer.
Data science could help tailor cancer therapy
Researchers are using data science to home in on therapies that will work best for specific patients, advancing precision oncology.
Routing cancer cells to the right path may boost treatment
Researchers at Stanford Medicine discover a certain molecule renders a type of cancer cell more susceptible to treatment.
Stanford doctor helps pediatric cancer patients evacuate Ukraine
A Stanford doctor traveled to Poland to help pediatric cancer patients evacuate from Ukraine and receive care.
Top 5 Scope stories of 2021
From the genetics of COVID-19, to cancer, to tonsils, this story is a wrap up of Scope's most read stories of 2021.
How to beat cancer? Find the genes that help it hide
Stanford Medicine researchers conducted an experiment to find new genes that, when knocked out, boost immune cells' cancer-killing ability.
Blood test predicts chances of lymphoma relapse after therapy
Stanford Medicine Scientists have devised a blood test to predict some cancer relapses after patients have already been treated.
Keeping treatment-resistant skin cancer cells in check
Anthony Oro is devoted to understanding the origin of basal cell carcinomas. Now he's found how some become resistant to a common treatment.
Why many stage 3 colorectal cancer patients skip chemo
As risk factors such as no health insurance and low income accumulate, colorectal cancer patients are less likely to finish chemotherapy.
Molecular clues could signal eye cancer survival odds
Stanford Medicine researchers discover that certain proteins can predict survival for patients with a type of eye cancer.
Former patient writes book for kids on stem cell transplants
A cancer survivor treated at Stanford has written a book to help kids facing stem cell transplant understand the procedure and approach it with courage.